RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation.
about
The 'invisible hand': regulation of RHO GTPases by RHOGDIsCellular mediators of renal vascular dysfunction in hypertensionExpression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heartRegulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucomaNitric oxide promotes epidermal stem cell migration via cGMP-Rho GTPase signalling.PDE5 inhibitor promotes melanin synthesis through the PKG pathway in B16 melanoma cellsAlcohol decreases RhoA activity through a nitric oxide (NO)/cyclic GMP(cGMP)/protein kinase G (PKG)-dependent pathway in the airway epitheliumInhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertensionProteolytic processing of cGMP-dependent protein kinase I mediates nuclear cGMP signaling in vascular smooth muscle cellsIncreased hepatic UCP2 expression in rats with nonalcoholic steatohepatitis is associated with upregulation of Sp1 binding to its motif within the proximal promoter region.Fucoxanthin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE and Nrf2-autophagy pathways.Coronary spasm that caused non-ST elevation myocardial infarction appeared in cath lab due to vasovagal reactionRegulation of retinoschisin secretion in Weri-Rb1 cells by the F-actin and microtubule cytoskeleton.GREBP, a cGMP-response element-binding protein repressing the transcription of natriuretic peptide receptor 1 (NPR1/GCA).PKG-1α leucine zipper domain defect increases pulmonary vascular tone: implications in hypoxic pulmonary hypertension.Current advances in the understanding of coronary vasospasm.Omega-3 fatty acid oxidation products prevent vascular endothelial cell activation by coplanar polychlorinated biphenyls.HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanismReduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin depositionS-nitrosylation in the regulation of gene transcriptionPleiotropic effects of statins in distal human pulmonary artery smooth muscle cellsIncreased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis.Comparative Proteomics Analysis Reveals L-Arginine Activates Ethanol Degradation Pathways in HepG2 Cells.Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges.The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells.Understanding and targeting the Rho kinase pathway in erectile dysfunction.Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase IαTranscriptional and post-transcriptional regulation of cGMP-dependent protein kinase (PKG-I): pathophysiological significanceHigh blood pressure arising from a defect in vascular function.H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and GProprotein convertases play an important role in regulating PKGI endoproteolytic cleavage and nuclear transport.Differential regulation of RhoA-mediated signaling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: independent modulation of TPalpha signaling by prostacyclin and nitric oxide.PKC ε Phosphorylates and Mediates the Cell Membrane Localization of RhoA.Inhibition of TRPC1/TRPC3 by PKG contributes to NO-mediated vasorelaxation.Soluble guanylate cyclase generation of cGMP regulates migration of MGE neurons.Regulation of smooth muscle contraction by small GTPases.NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism.Rho GTPases in the regulation of pulmonary vascular barrier function.Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.
P2860
Q24606819-D32A93D3-D706-4585-8270-61636FDF2D65Q24644250-C080D035-B673-4339-A880-65CAA177BFE4Q24685159-06E4D7B7-5583-4534-8D27-7761D949AD33Q26861763-6753AD4E-9614-487B-8AE6-ABCC448FC037Q27321422-9EDDD5BF-662E-464C-B679-1B58C19E8183Q28262626-7DEA568B-AD58-4D73-9698-5605F11920B5Q28390716-8775B8B6-6F35-486D-B7B9-D028371D8C20Q28566149-23C7BDF3-653C-4A7E-8269-3C22AF943EA6Q28572691-556D1A30-0641-4F83-9336-13F9FF141612Q33342303-33500323-EE36-4909-A7F4-35F89ACAC108Q33587745-148B8BA1-CD88-4E80-8BD7-9AA007BBC95FQ33941337-FA8C7BA8-472C-46F0-B36F-22B30D0789C3Q33954586-4BBA71F3-3738-4B1C-9518-AB52FB5AAE90Q33966980-D1FC58B4-C512-45D1-B5F5-5E3D3D6E1F25Q34295259-BF8878DF-7F1C-4C7E-AB7E-B35933E1FC48Q34389782-3112EA02-8F76-4A34-8761-E1F74C43302AQ34516600-AE8F8E56-EECF-4F0F-80E5-441F82A13241Q35007551-07BB595F-3CA6-45EB-9878-821C500A468FQ35395483-CA2075F7-C440-4C14-BD71-FE32996B8F2FQ35492444-95B5530A-1D03-4B39-90D1-EDC18E4D03E8Q35541250-18365D50-EFDA-46D9-8BF2-D5265C13D0CBQ35854712-0821E08D-9DED-4BA2-9341-17CBE019DF2FQ35894523-7AA10057-3A9D-4C5E-BB6E-26B0DBE5496AQ35959936-C50F4401-5738-4965-8C50-93970A733D9DQ36219699-346B76BE-64BE-4E44-9533-C547CBDCCB42Q36364561-5CC79E91-646C-497A-9104-71A42EC863F1Q36416633-D9774DD8-D4A5-4256-AB97-1B50C065150BQ36436116-A1E43F70-59EA-4BE0-958B-8455FC1DC287Q36529020-5B295D3D-9B0D-4ED3-B07E-884D12EFF733Q36638652-8245AC95-A8C8-4B92-A353-18A2237853A8Q37002373-079874D1-51D5-4360-93A9-10EFEF9CCFC4Q37054485-427B9194-E62D-439D-9AAD-0071AE669A00Q37189926-B621C413-07C7-4A12-BAFD-778A352AC64EQ37245128-32C452C9-7503-42B4-8AC4-B67F54AB1707Q37264474-80257EB9-8BD6-4CE0-BDA3-B18C4C7A7ABAQ37399819-83083271-C57D-4684-B437-971564A7DB31Q37649264-02102FB0-50C5-4316-922F-8307692C21E0Q37824455-D319BA5A-7B5E-4E82-8789-608E0B2B9771Q38193703-846728EC-2E89-4FCB-97FB-1B34CBED053CQ38367694-33EFB972-69F5-4C2C-BE61-3CEA9F0E7627
P2860
RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
RhoA expression is controlled ...... ent protein kinase activation.
@en
RhoA expression is controlled ...... ent protein kinase activation.
@nl
type
label
RhoA expression is controlled ...... ent protein kinase activation.
@en
RhoA expression is controlled ...... ent protein kinase activation.
@nl
prefLabel
RhoA expression is controlled ...... ent protein kinase activation.
@en
RhoA expression is controlled ...... ent protein kinase activation.
@nl
P2093
P2860
P356
P1476
RhoA expression is controlled ...... ent protein kinase activation.
@en
P2093
Céline Marionneau
Gervaise Loirand
Malvyne Rolli-Derkinderen
Pierre Pacaud
Vincent Sauzeau
P2860
P304
P356
10.1074/JBC.M212776200
P407
P577
2003-01-09T00:00:00Z